Parametric Portfolio Associates’s Arcus Biosciences RCUS Stock Holding History

Parametric Portfolio Associates’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.3M	Buy	72,994 +19,018	+35%	+$637K	﹤0.01%	2344
2021 Q4	$2.18M	Buy	53,976 +24,059	+80%	+$933K	﹤0.01%	2387
2021 Q3	$1.04M	Buy	29,917 +145	+0.5%	+$4.51K	﹤0.01%	2795
2021 Q2	$818K	Sell	29,772 -4,873	-14%	-$139K	﹤0.01%	2861
2021 Q1	$973K	Buy	34,645 +5,335	+18%	+$186K	﹤0.01%	3175
2020 Q4	$761K	Buy	29,310 +7,973	+37%	+$193K	﹤0.01%	3185
2020 Q3	$366K	Sell	21,337 -29,869	-58%	-$667K	﹤0.01%	3404
2020 Q2	$1.27M	Buy	51,206 +34,584	+208%	+$933K	﹤0.01%	2788
2020 Q1	$231K	Buy	+16,622	New	+$207K	﹤0.01%	3490

Other funds holding RCUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Parametric Portfolio Associates's RCUS Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Arcus Biosciences (RCUS) stake by 35% in Q1 2022, buying an estimated $637K and bringing the position to 72,994 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Parametric Portfolio Associates first reported a position in RCUS in Q1 2020 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold RCUS as of Q1 2022.

Parametric Portfolio Associates held 72,994 shares of Arcus Biosciences worth $2.3M as of Q1 2022.
Parametric Portfolio Associates bought 19,018 Arcus Biosciences shares in Q1 2022, an estimated $637K.
Arcus Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2344 holding.
Parametric Portfolio Associates first reported a position in Arcus Biosciences in Q1 2020 and has held it in 9 quarters since.
157 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.